Войти в систему Зарегистрироваться бесплатно

Interpace Biosciences Inc Денежные средства на акцию

Что обозначает Денежные средства на акцию в Interpace Biosciences Inc?

Денежные средства на акцию Interpace Biosciences Inc является 1.21

Какое определение для Денежные средства на акцию?

Денежные средства на акцию - это наличные денежные средства компании, поделенные на акции компании в обращении.

Cash per share, sometimes called the cash share ratio, is the total cash per share. Cash on hand is reported on the balance sheet. Cash per share is calculated by dividing cash on hand by the total number of shares. Cash per share is the percentage of a firm's share price that is immediately accessible for spending. Cash per share consists of cash and short-term investments. It is money that a firm has on hand and does not come from borrowing or financing activities.

When a firm has a high cash per share, significant percentage of its assets is in a very liquid form. This can indicate economic uncertainty and unwillingness to invest given the current economic climate. High levels of cash per share can indicate that a firm is performing well and is able to reinvest in itself but high cash per share does not always indicate overall financial strength.

Денежные средства на акцию компаний в Health Care сектор на NASDAQ по сравнению с Interpace Biosciences Inc

Что делает Interpace Biosciences Inc?

advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.

Компании с денежные средства на акцию похож на Interpace Biosciences Inc